Moat Ross
CIK 1857177
Transactions on file
39
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-09-03 | 2026-09-01 | KNSA Kiniksa Pharmaceuticals International, plc | CHIEF OPERATING OFFICER | Tax | 4,007 | $317.7K | -2.8% | open → |
| 2026-09-03 | 2026-09-01 | KNSA Kiniksa Pharmaceuticals International, plc | CHIEF OPERATING OFFICER | Exer. | 2,457 | $0.00 | — | open → |
| 2026-09-03 | 2026-09-01 | KNSA Kiniksa Pharmaceuticals International, plc | CHIEF OPERATING OFFICER | Exer. | 1,740 | $0.00 | — | open → |
| 2026-09-03 | 2026-09-01 | KNSA Kiniksa Pharmaceuticals International, plc | CHIEF OPERATING OFFICER | Exer. | 1,611 | $0.00 | — | open → |
| 2026-09-03 | 2026-09-01 | KNSA Kiniksa Pharmaceuticals International, plc | CHIEF OPERATING OFFICER | Exer. | 2,477 | $0.00 | — | open → |
| 2026-04-13 | 2026-04-09 | KNSA Kiniksa Pharmaceuticals International, plc | CHIEF OPERATING OFFICER | Sale | 1,703 | $79.5K | +65.1% | open → |
| 2025-03-19 | 2025-03-16 | KNSA Kiniksa Pharmaceuticals International, plc | Officer CHIEF COMMERCIAL OFFICER | Exer. | 994 | — | — | open → |
| 2025-03-19 | 2025-03-16 | KNSA Kiniksa Pharmaceuticals International, plc | Officer CHIEF COMMERCIAL OFFICER | Tax | 292 | $6.6K | +241.0% | open → |
| 2025-03-19 | 2025-01-15 | KNSA Kiniksa Pharmaceuticals International, plc | Officer CHIEF COMMERCIAL OFFICER | Grant | 1,118 | $17.9K | +381.8% | open → |
| 2025-04-03 | 2025-04-01 | KNSA Kiniksa Pharmaceuticals International, plc | Officer CHIEF COMMERCIAL OFFICER | Exer. | 1,611 | — | — | open → |
| 2025-04-03 | 2025-04-01 | KNSA Kiniksa Pharmaceuticals International, plc | Officer CHIEF COMMERCIAL OFFICER | Tax | 473 | $10.3K | +254.1% | open → |
| 2025-04-03 | 2025-04-01 | KNSA Kiniksa Pharmaceuticals International, plc | Officer CHIEF COMMERCIAL OFFICER | Exer. | 1,741 | — | — | open → |
| 2025-04-03 | 2025-04-01 | KNSA Kiniksa Pharmaceuticals International, plc | Officer CHIEF COMMERCIAL OFFICER | Tax | 511 | $11.1K | +254.1% | open → |
| 2025-04-09 | 2025-04-07 | KNSA Kiniksa Pharmaceuticals International, plc | Officer CHIEF COMMERCIAL OFFICER | Tax | 727 | $14.7K | +280.1% | open → |
| 2025-04-09 | 2025-04-07 | KNSA Kiniksa Pharmaceuticals International, plc | Officer CHIEF COMMERCIAL OFFICER | Exer. | 2,477 | — | — | open → |
| 2025-04-23 | 2025-04-21 | KNSA Kiniksa Pharmaceuticals International, plc | Officer CHIEF COMMERCIAL OFFICER | Sale | 18,259 | $370.5K | +279.9% | open → |
| 2025-05-01 | 2025-04-29 | KNSA Kiniksa Pharmaceuticals International, plc | Officer CHIEF COMMERCIAL OFFICER | Sale | 64,035 | $1.61M | +205.8% | open → |
| 2025-05-01 | 2025-04-29 | KNSA Kiniksa Pharmaceuticals International, plc | Officer CHIEF COMMERCIAL OFFICER | Exer. | 15,307 | $164.7K | +616.4% | open → |
| 2025-05-01 | 2025-04-29 | KNSA Kiniksa Pharmaceuticals International, plc | Officer CHIEF COMMERCIAL OFFICER | Exer. | 6,296 | $81.7K | +494.4% | open → |
| 2025-05-01 | 2025-04-29 | KNSA Kiniksa Pharmaceuticals International, plc | Officer CHIEF COMMERCIAL OFFICER | Exer. | 20,000 | $310.0K | +397.4% | open → |
| 2025-05-01 | 2025-04-29 | KNSA Kiniksa Pharmaceuticals International, plc | Officer CHIEF COMMERCIAL OFFICER | Exer. | 15,000 | $232.8K | +396.7% | open → |
| 2025-05-01 | 2025-05-01 | KNSA Kiniksa Pharmaceuticals International, plc | Officer CHIEF COMMERCIAL OFFICER | Exer. | 13,406 | $179.0K | +477.5% | open → |
| 2025-05-01 | 2025-05-01 | KNSA Kiniksa Pharmaceuticals International, plc | Officer CHIEF COMMERCIAL OFFICER | Exer. | 8,671 | $96.2K | +594.5% | open → |
| 2025-05-01 | 2025-05-01 | KNSA Kiniksa Pharmaceuticals International, plc | Officer CHIEF COMMERCIAL OFFICER | Exer. | 1,157 | $20.5K | +334.1% | open → |
| 2025-05-01 | 2025-05-01 | KNSA Kiniksa Pharmaceuticals International, plc | Officer CHIEF COMMERCIAL OFFICER | Sale | 23,234 | $651.0K | +175.1% | open → |
| 2025-05-01 | 2025-04-29 | KNSA Kiniksa Pharmaceuticals International, plc | Officer CHIEF COMMERCIAL OFFICER | Exer. | 7,432 | $89.0K | +544.0% | open → |
| 2025-05-05 | 2025-05-05 | KNSA Kiniksa Pharmaceuticals International, plc | Officer CHIEF COMMERCIAL OFFICER | Exer. | 6,272 | $111.4K | +334.1% | open → |
| 2025-05-05 | 2025-05-05 | KNSA Kiniksa Pharmaceuticals International, plc | Officer CHIEF COMMERCIAL OFFICER | Sale | 6,272 | $175.6K | +175.3% | open → |
| 2025-05-05 | 2025-05-02 | KNSA Kiniksa Pharmaceuticals International, plc | Officer CHIEF COMMERCIAL OFFICER | Sale | 3,850 | $107.8K | +175.3% | open → |
| 2025-05-05 | 2025-05-02 | KNSA Kiniksa Pharmaceuticals International, plc | Officer CHIEF COMMERCIAL OFFICER | Exer. | 3,850 | $68.4K | +334.1% | open → |
| 2025-06-05 | 2025-06-03 | KNSA Kiniksa Pharmaceuticals International, plc | Officer CHIEF COMMERCIAL OFFICER | Exer. | 27,594 | $368.4K | +477.5% | open → |
| 2025-06-05 | 2025-06-03 | KNSA Kiniksa Pharmaceuticals International, plc | Officer CHIEF COMMERCIAL OFFICER | Sale | 27,594 | $800.8K | +165.6% | open → |
| 2025-09-03 | 2025-09-01 | KNSA Kiniksa Pharmaceuticals International, plc | Officer CHIEF CORP. & COMM. OFFICER | Exer. | 1,741 | — | — | open → |
| 2025-09-03 | 2025-09-01 | KNSA Kiniksa Pharmaceuticals International, plc | Officer CHIEF CORP. & COMM. OFFICER | Exer. | 1,611 | — | — | open → |
| 2025-09-03 | 2025-09-01 | KNSA Kiniksa Pharmaceuticals International, plc | Officer CHIEF CORP. & COMM. OFFICER | Exer. | 2,477 | — | — | open → |
| 2025-09-03 | 2025-09-01 | KNSA Kiniksa Pharmaceuticals International, plc | Officer CHIEF CORP. & COMM. OFFICER | Tax | 2,819 | $94.4K | +130.2% | open → |
| 2025-09-03 | 2025-09-02 | KNSA Kiniksa Pharmaceuticals International, plc | Officer CHIEF CORP. & COMM. OFFICER | Tax | 481 | $16.5K | +124.9% | open → |
| 2025-09-03 | 2025-09-02 | KNSA Kiniksa Pharmaceuticals International, plc | Officer CHIEF CORP. & COMM. OFFICER | Exer. | 994 | — | — | open → |
| 2025-09-08 | 2025-09-04 | KNSA Kiniksa Pharmaceuticals International, plc | Officer CHIEF CORP. & COMM. OFFICER | Sale | 3,523 | $124.4K | +118.3% | open → |
